 Nina Ma
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 4 | 2021 | 340 | 1.050 |
Why?
| | Osteoporosis | 4 | 2023 | 225 | 0.860 |
Why?
| | Osteolysis | 1 | 2022 | 12 | 0.850 |
Why?
| | Carpal Bones | 1 | 2022 | 14 | 0.840 |
Why?
| | Dietary Supplements | 3 | 2021 | 458 | 0.800 |
Why?
| | Fractures, Bone | 3 | 2023 | 373 | 0.630 |
Why?
| | Bone and Bones | 3 | 2020 | 280 | 0.610 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2017 | 4 | 0.610 |
Why?
| | Bone Diseases, Developmental | 1 | 2017 | 12 | 0.600 |
Why?
| | Bone Development | 1 | 2017 | 48 | 0.590 |
Why?
| | Infant Health | 1 | 2017 | 21 | 0.570 |
Why?
| | Scurvy | 1 | 2016 | 12 | 0.530 |
Why?
| | Genetic Association Studies | 1 | 2017 | 344 | 0.520 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2017 | 147 | 0.520 |
Why?
| | Food Preferences | 1 | 2016 | 108 | 0.490 |
Why?
| | Familial Hypophosphatemic Rickets | 2 | 2016 | 4 | 0.470 |
Why?
| | Autistic Disorder | 1 | 2016 | 161 | 0.450 |
Why?
| | Congenital Hypothyroidism | 2 | 2012 | 11 | 0.450 |
Why?
| | Optic Nerve Diseases | 2 | 2012 | 31 | 0.440 |
Why?
| | Rheumatology | 2 | 2023 | 89 | 0.410 |
Why?
| | Bone Density | 6 | 2023 | 432 | 0.400 |
Why?
| | Vitamin D Deficiency | 2 | 2016 | 158 | 0.390 |
Why?
| | Alkaline Phosphatase | 3 | 2020 | 143 | 0.370 |
Why?
| | Bone Diseases, Metabolic | 2 | 2022 | 53 | 0.370 |
Why?
| | Hospitalization | 2 | 2017 | 1754 | 0.360 |
Why?
| | Transcription Factors | 1 | 2017 | 1531 | 0.350 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2009 | 19 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2108 | 0.330 |
Why?
| | RNA Splice Sites | 1 | 2009 | 34 | 0.330 |
Why?
| | Mutation | 3 | 2022 | 3350 | 0.320 |
Why?
| | Receptors, Calcitriol | 1 | 2009 | 53 | 0.320 |
Why?
| | Hypophosphatemia | 2 | 2020 | 18 | 0.320 |
Why?
| | Gynecomastia | 1 | 2008 | 4 | 0.320 |
Why?
| | Calcium | 3 | 2017 | 1104 | 0.310 |
Why?
| | Thymus Gland | 1 | 2009 | 296 | 0.310 |
Why?
| | Infant Formula | 2 | 2020 | 74 | 0.300 |
Why?
| | Bacterial Infections | 1 | 2009 | 219 | 0.290 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 286 | 0.290 |
Why?
| | Puberty | 1 | 2008 | 137 | 0.280 |
Why?
| | Child | 12 | 2023 | 18407 | 0.240 |
Why?
| | Child, Preschool | 8 | 2020 | 9093 | 0.230 |
Why?
| | Infant | 9 | 2020 | 7946 | 0.220 |
Why?
| | Phenotype | 2 | 2022 | 2815 | 0.210 |
Why?
| | Humans | 23 | 2023 | 115042 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1747 | 0.200 |
Why?
| | Radiography | 2 | 2017 | 827 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2022 | 76 | 0.190 |
Why?
| | Mutation, Missense | 1 | 2022 | 296 | 0.180 |
Why?
| | Absorptiometry, Photon | 3 | 2022 | 223 | 0.180 |
Why?
| | Hypophosphatasia | 1 | 2020 | 2 | 0.180 |
Why?
| | Male | 15 | 2020 | 55731 | 0.170 |
Why?
| | Inservice Training | 1 | 2020 | 107 | 0.170 |
Why?
| | Spinal Fusion | 1 | 2022 | 213 | 0.160 |
Why?
| | Mentors | 1 | 2020 | 158 | 0.160 |
Why?
| | Mentoring | 1 | 2020 | 101 | 0.150 |
Why?
| | Interprofessional Relations | 1 | 2020 | 251 | 0.150 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2018 | 17 | 0.150 |
Why?
| | Female | 14 | 2020 | 59613 | 0.150 |
Why?
| | Multimorbidity | 1 | 2017 | 33 | 0.140 |
Why?
| | Syndrome | 1 | 2017 | 337 | 0.140 |
Why?
| | Adrenodoxin | 1 | 2016 | 1 | 0.140 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 16 | 0.140 |
Why?
| | Bone Diseases | 1 | 2017 | 57 | 0.130 |
Why?
| | Nutritional Status | 1 | 2018 | 287 | 0.130 |
Why?
| | Ascorbic Acid | 1 | 2016 | 110 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 486 | 0.120 |
Why?
| | Vitamins | 1 | 2016 | 151 | 0.120 |
Why?
| | Precision Medicine | 1 | 2018 | 340 | 0.120 |
Why?
| | Body Composition | 1 | 2018 | 586 | 0.120 |
Why?
| | Adolescent | 5 | 2018 | 17864 | 0.110 |
Why?
| | Hyperparathyroidism, Secondary | 1 | 2012 | 9 | 0.110 |
Why?
| | Sunscreening Agents | 1 | 2012 | 17 | 0.110 |
Why?
| | Length of Stay | 1 | 2017 | 950 | 0.100 |
Why?
| | Calcium, Dietary | 1 | 2012 | 55 | 0.100 |
Why?
| | Thyrotropin | 1 | 2012 | 99 | 0.100 |
Why?
| | Diphosphonates | 1 | 2012 | 51 | 0.100 |
Why?
| | Risk Factors | 3 | 2017 | 8642 | 0.100 |
Why?
| | Bone Density Conservation Agents | 1 | 2012 | 61 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1721 | 0.100 |
Why?
| | United States | 4 | 2023 | 12226 | 0.100 |
Why?
| | Osteoporotic Fractures | 1 | 2012 | 56 | 0.100 |
Why?
| | Vision Disorders | 1 | 2012 | 130 | 0.090 |
Why?
| | Osteolysis, Essential | 1 | 2010 | 1 | 0.090 |
Why?
| | Lymphangioma | 1 | 2010 | 7 | 0.090 |
Why?
| | Hyperprolactinemia | 1 | 2010 | 4 | 0.090 |
Why?
| | Thyroid Function Tests | 1 | 2010 | 11 | 0.090 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 1990 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2017 | 3015 | 0.090 |
Why?
| | Age Factors | 1 | 2017 | 2894 | 0.090 |
Why?
| | Vision Tests | 1 | 2010 | 15 | 0.090 |
Why?
| | Hypopituitarism | 1 | 2010 | 15 | 0.090 |
Why?
| | Soft Tissue Neoplasms | 1 | 2010 | 90 | 0.090 |
Why?
| | Phytohemagglutinins | 1 | 2009 | 27 | 0.090 |
Why?
| | Endocrine System Diseases | 1 | 2009 | 30 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2551 | 0.080 |
Why?
| | Lymphopoiesis | 1 | 2009 | 24 | 0.080 |
Why?
| | Glucocorticoids | 2 | 2023 | 535 | 0.080 |
Why?
| | Homeostasis | 1 | 2012 | 578 | 0.080 |
Why?
| | Cell Count | 1 | 2009 | 304 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2009 | 257 | 0.080 |
Why?
| | Exercise Therapy | 1 | 2012 | 351 | 0.080 |
Why?
| | Androgen-Insensitivity Syndrome | 1 | 2008 | 5 | 0.080 |
Why?
| | Stem Cell Transplantation | 1 | 2009 | 149 | 0.080 |
Why?
| | Diarrhea | 1 | 2009 | 171 | 0.080 |
Why?
| | Exons | 1 | 2009 | 301 | 0.080 |
Why?
| | Age of Onset | 1 | 2010 | 449 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 372 | 0.080 |
Why?
| | Risk Assessment | 1 | 2017 | 2976 | 0.080 |
Why?
| | Fever | 1 | 2009 | 280 | 0.080 |
Why?
| | Hypogonadism | 1 | 2008 | 75 | 0.080 |
Why?
| | Immunization | 1 | 2009 | 400 | 0.070 |
Why?
| | Administration, Oral | 1 | 2009 | 730 | 0.070 |
Why?
| | Androgens | 1 | 2008 | 167 | 0.070 |
Why?
| | Chronic Disease | 1 | 2012 | 1591 | 0.070 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 242 | 0.070 |
Why?
| | Recurrence | 1 | 2009 | 941 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2016 | 5040 | 0.070 |
Why?
| | Estrogens | 1 | 2008 | 313 | 0.060 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1042 | 0.060 |
Why?
| | Base Sequence | 1 | 2009 | 2119 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2796 | 0.060 |
Why?
| | Prospective Studies | 2 | 2018 | 6232 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2341 | 0.050 |
Why?
| | Pregnancy | 2 | 2009 | 5520 | 0.050 |
Why?
| | Nutritive Value | 1 | 2020 | 30 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2524 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 212 | 0.040 |
Why?
| | Minerals | 1 | 2020 | 37 | 0.040 |
Why?
| | Aging | 1 | 2009 | 1624 | 0.040 |
Why?
| | Physicians, Women | 1 | 2020 | 55 | 0.040 |
Why?
| | Isoenzymes | 1 | 2020 | 286 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 203 | 0.040 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 133 | 0.040 |
Why?
| | Minority Groups | 1 | 2020 | 228 | 0.040 |
Why?
| | Adult | 4 | 2023 | 30656 | 0.040 |
Why?
| | Career Choice | 1 | 2020 | 181 | 0.040 |
Why?
| | Universities | 1 | 2020 | 339 | 0.040 |
Why?
| | Social Media | 1 | 2020 | 133 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2018 | 74 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2020 | 256 | 0.040 |
Why?
| | Rickets | 1 | 2017 | 6 | 0.040 |
Why?
| | Social Support | 1 | 2020 | 528 | 0.030 |
Why?
| | Phosphorus | 1 | 2017 | 81 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 678 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 353 | 0.030 |
Why?
| | Energy Intake | 1 | 2018 | 421 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 729 | 0.030 |
Why?
| | Vision Screening | 1 | 2012 | 9 | 0.030 |
Why?
| | Physicians | 1 | 2020 | 772 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1321 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12547 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4420 | 0.020 |
Why?
| | Visual Acuity | 1 | 2012 | 274 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 1967 | 0.020 |
Why?
| | Endocrinology | 1 | 2009 | 69 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3334 | 0.020 |
Why?
| | Fetal Development | 1 | 2009 | 247 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3419 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2009 | 430 | 0.020 |
Why?
| | Biomedical Research | 1 | 2009 | 585 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 10498 | 0.010 |
Why?
|
|
Ma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|